Close

Pfizer (PFE) Gets FDA Approval for BOSULIF as Ph+ CML Treatment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/19/2024

1. NFLX
2. TSM
3. SPY
4. INFY
5. LVS
6. TSLA
7. CSX
8. EFX
9. ISRG
10. UAL


Go back to Pfizer (PFE) Gets FDA Approval for BOSULIF as Ph+ CML Treatment
Pfizer Inc. (NYSE: PFE) Delayed: 25.39 --0 (-0%)
Previous Close $25.39    52 Week High $37.39 
Open $25.39    52 Week Low $28.25 
Day High $25.39    P/E 15.39 
Day Low $25.39    EPS $1.65 
Volume 30,327